Evidence map›Paper›PMID 42148555›Full record

ArticleThe Biochemical journal2026

Heparan sulfate promotes autoactivation of procathepsin K by destabilizing the propeptide-catalytic domain interaction.

Huanmeng Hao, Xiaoxiao Zhang, Jian Liu, Ding Xu

Abstract read
In one paragraph

Article in The Biochemical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Huanmeng HaoDepartment of Orthopaedics, School of Medicine, Emory University, Atlanta, GA, U.S.A.
Xiaoxiao ZhangDepartment of Oral Biology, School of Dental Medicine, University at Buffalo, the State University of New York, Buffalo, NY, U.S.A.
Jian LiuDivision of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, U.S.A.
Ding XuDepartment of Orthopaedics, School of Medicine, Emory University, Atlanta, GA, U.S.A.ORCID 0000-0001-9380-2712

Funding

Regulation of Osteoclastogenesis and Arthritic Bone Resorption by RBP-JR01AR071463 · NIAMS · HOSPITAL FOR SPECIAL SURGERY · PI Baohong Zhao · 2017 to 2026
$4.0M
The role of heparan sulfate in cathepsin K biologyR01DE031273 · NIDCR · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI JIAN LIU, Ding Xu · 2022 to 2026
$2.7M
Regulation of bone homeostasis and remodeling by long noncoding RNA Malat1R01AR078212 · NIAMS · HOSPITAL FOR SPECIAL SURGERY · PI Baohong Zhao · 2021 to 2026
$2.2M
HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) R01AR078212HHS | NIH | National Institute of Dental and Craniofacial Research (NIDR) R01DE031273NIAMS NIH HHS R01 AR071463NIDCR NIH HHS R01 DE031273
6 · The paper itself

Abstract

Procathepsin K (pro-CtsK) is the zymogen of cathepsin K (CtsK), a collagenase that is essential for bone resorption. Pro-CtsK is known to bind heparan sulfate (HS), but the biological significance of the interaction remains unclear. Here, we report that HS accelerates the autoprocessing of pro-CtsK in a manner dependent on both sulfation pattern and oligosaccharide length. We discovered a previously unknown electrostatic interaction between the propeptide and the catalytic domain, which stabilizes the conformation of the propeptide and prevents it from intermolecular proteolytic activation. HS accelerates autoprocessing of pro-CtsK by disrupting this critical electrostatic interaction. Mechanistically, HS competes with two glutamic acids in the propeptide for binding to three basic residues on the catalytic domain, thereby substantially altering the conformation of the propeptide and making it more labile for autoprocessing. We further discovered that HS is highly enriched in secretory lysosomes of osteoclasts and might be directly involved in autoactivation of CtsK.

Indexed as

Cathepsin KEnzyme PrecursorsHeparan SulfateAnimalsCatalytic DomainEnzyme ActivationHumansLysosomesOsteoclastsCathepsin KEnzyme PrecursorsHeparan SulfatecathepsinglycosaminoglyanlysosomeosteoclastsProtease

Identifiers

PMID42148555
PMCPMC13296955

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.